Skip to main content
I.Ceram logo

I.Ceram — Investor Relations & Filings

Ticker · ALICR ISIN · FR0011511971 LEI · 969500R28RHD3HDEIL86 PA Manufacturing
Open in API
Filings indexed 157 across all filing types
Latest filing 2022-04-29 Report Publication Anno…
Country FR France
Listing PA ALICR

About I.Ceram

https://www.iceram.fr/

I.Ceram specializes in the design, manufacture, and marketing of orthopedic and reconstructive implants. The company's core technology is centered on porous alumina bioceramics, though it also utilizes metals and polymers. A key innovation is the development of active implants, such as its Ceramil line, which can be loaded with antibiotics like gentamicin. This feature enables the localized delivery of medication directly to bone tissue to prevent and treat infections post-surgery. The product portfolio includes implants for various joints and a bioceramic sternal implant designed for reconstructive procedures.

Recent filings

Filing Released Lang Actions
I.CERAM : Mise à disposition du Document d'Enregistrement Universel 2021
Report Publication Announcement Classification · 1% confidence The document is a short announcement (2113 characters) titled "Mise à disposition du Document d'Enregistrement Universel 2021" (Making available of the 2021 Universal Registration Document). It explicitly states that the DEU 2021, which includes the 2021 annual report, management report, and accounts for the year ended December 31, 2021, has been filed with the AMF and is now available for consultation and download on the company's website and the AMF website. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a full report (like the Annual Report/10-K content mentioned within the DEU) should be classified as a Report Publication Announcement (RPA).
2022-04-29 French
Document d'enregistrement universel 2021
Regulatory Filings Classification · 1% confidence The document text is extremely short and states, 'Document supprimé à la demande de l'émetteur' (Document deleted at the request of the issuer). This indicates a regulatory action or administrative removal rather than a standard financial report (like 10-K, ER, or IR). Since there is no specific category for 'document deletion notice,' and it is a regulatory/administrative action concerning a filing, the most appropriate fallback category is Regulatory Filings (RNS), as it represents an official, non-standard regulatory communication.
2022-04-28 French
I.CERAM : Brevet délivré aux Etats-Unis sur l'implant en céramique poreuse chargé en principes actifs
Regulatory Filings Classification · 1% confidence The document is titled with a date and time stamp ("Communiqué de presse Limoges, 21 avril 2022 – 18h") and discusses a significant corporate event: the granting of a US patent for an innovative medical implant. It includes quotes from the CEO and mentions future events like the AGM. This structure strongly indicates a press release announcing important, non-periodic corporate news, such as intellectual property milestones or strategic developments. Since there is no specific category for a general press release about a patent, and it is not a formal regulatory filing like a 10-K, ER, or IR, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for official regulatory announcements that don't fit elsewhere. The document length (5058 chars) is substantial enough to be the primary announcement, not just a notification of an attachment (ruling 2 does not apply).
2022-04-21 French
I.CERAM - Résultats annuels 2021
Earnings Release Classification · 1% confidence The document is titled "Résultats annuels 2021" (Annual Results 2021) and contains a detailed table of consolidated key figures for 2021 compared to 2020, including revenue, gross margin, and net result. It explicitly states that the Board of Directors approved the consolidated annual accounts for the 2021 fiscal year. Although it mentions the audit reports are being issued, the core content is the comprehensive summary of the full year's financial performance. This strongly indicates it is an Annual Report or a document closely associated with it, like an Earnings Release (ER) or Management Discussion & Analysis (MDA). Given the depth of financial data and the explicit reference to 'annual accounts' and the full year's performance, it aligns best with the comprehensive nature of an Annual Report (10-K) or a detailed Earnings Release/Management Report. Since it presents the full year's results and analysis, and is not just a brief press release, it leans towards a comprehensive report. However, in the context of non-US filings, a detailed annual results summary often maps to the 'Annual Report' category (10-K) or 'Interim Report' (IR) if it were quarterly. Since it is explicitly 'annuels' (annual) and contains detailed financial breakdowns, it is classified as an Annual Report (10-K) equivalent, or if we must choose from the provided list, the closest comprehensive annual document type is 10-K, or potentially MDA if it's primarily management commentary accompanying the results. Given the structure and focus on the full year's financial statements summary, 10-K is the most appropriate fit for a full-year financial disclosure. FY 2021
2022-03-29 French
I.CERAM : Implantation d’un sternum en biocéramique poreuse chez une adolescente de 13 ans atteinte d’une tumeur du sternum
Regulatory Filings Classification · 1% confidence The document is a press release or announcement from a company (I.CERAM) detailing the publication of a scientific article in a medical journal (*European Journal of Pediatric Surgery Reports*) regarding the successful use of their bioceramic sternal prosthesis. The text focuses on the scientific validation and clinical results of their product, which is a form of corporate communication aimed at investors and the public, highlighting positive developments. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is an announcement about external validation (a scientific publication). Since there is no specific category for 'Scientific Publication Announcement' and it is not a standard financial report, it falls best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, although 'Investor Presentation' (IP) or 'Report Publication Announcement' (RPA) could be considered if it were announcing one of their own reports. Given the context of announcing a third-party scientific publication, RNS is the most appropriate fallback for non-standard corporate news.
2022-02-23 French
I.CERAM - Chiffre d'affaires 2021 porté par les ventes à l'export
Earnings Release Classification · 1% confidence The document provides a summary of the company's 2021 financial performance, specifically highlighting the annual revenue ('Chiffre d'affaires annuel') and growth figures. It explicitly states that the figures are 'non audités' (unaudited) and concludes with a forward-looking statement about the next communication: 'Prochaine communication : Résultats annuels 2021 – 29 mars 2022'. This structure—a brief summary of period results, often unaudited, preceding the full official report—is characteristic of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) or the Interim Report (IR), as it covers the full year but is presented as a preliminary announcement before the official results date mentioned. It is too detailed for just a Report Publication Announcement (RPA) because it contains substantive financial data and commentary. FY 2021
2022-01-25 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.